537 related articles for article (PubMed ID: 24053611)
1. Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?
Li Y; Liu Y; Wang Z; Jiang Y
Expert Opin Biol Ther; 2013 Nov; 13(11):1515-22. PubMed ID: 24053611
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for Alzheimer's disease.
Wang W; Fan L; Xu D; Wen Z; Yu R; Ma Q
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):807-14. PubMed ID: 22899646
[TBL] [Abstract][Full Text] [Related]
4. Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease.
Panza F; Frisardi V; Imbimbo BP; D'Onofrio G; Pietrarossa G; Seripa D; Pilotto A; Solfrizzi V
Immunotherapy; 2010 Nov; 2(6):767-82. PubMed ID: 21091109
[TBL] [Abstract][Full Text] [Related]
5. A beta immunotherapy: Lessons learned for potential treatment of Alzheimer's disease.
Schenk DB; Seubert P; Grundman M; Black R
Neurodegener Dis; 2005; 2(5):255-60. PubMed ID: 16909006
[TBL] [Abstract][Full Text] [Related]
6. Antibody-based therapy in Alzheimer's disease.
Pul R; Dodel R; Stangel M
Expert Opin Biol Ther; 2011 Mar; 11(3):343-57. PubMed ID: 21261567
[TBL] [Abstract][Full Text] [Related]
7. Amyloid beta peptide immunotherapy in Alzheimer disease.
Delrieu J; Ousset PJ; Voisin T; Vellas B
Rev Neurol (Paris); 2014 Dec; 170(12):739-48. PubMed ID: 25459121
[TBL] [Abstract][Full Text] [Related]
8. Vaccines: chasing the dream.
Schnabel J
Nature; 2011 Jul; 475(7355):S18-9. PubMed ID: 21760578
[No Abstract] [Full Text] [Related]
9. Passive Immunotherapies Targeting Amyloid Beta and Tau Oligomers in Alzheimer's Disease.
Vander Zanden CM; Chi EY
J Pharm Sci; 2020 Jan; 109(1):68-73. PubMed ID: 31647950
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's amyloid immunotherapy: quo vadis?
Gandy S; Heppner FL
Lancet Neurol; 2005 Aug; 4(8):452-3. PubMed ID: 16033686
[No Abstract] [Full Text] [Related]
11. Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?
Panza F; Logroscino G; Imbimbo BP; Solfrizzi V
Curr Opin Psychiatry; 2014 Mar; 27(2):128-37. PubMed ID: 24445401
[TBL] [Abstract][Full Text] [Related]
12. [Development of antibodies for immunotherapy of Alzheimer's disease].
Matsumoto SE; Jin H; Takeda K; Hasegawa Y; Motoi Y; Hattori N; Tabira T
Rinsho Shinkeigaku; 2012; 52(11):1168-70. PubMed ID: 23196552
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning.
Schenk D
Nat Rev Neurosci; 2002 Oct; 3(10):824-8. PubMed ID: 12360327
[No Abstract] [Full Text] [Related]
14. Mechanisms of A beta plaque clearance following passive A beta immunization.
Morgan D
Neurodegener Dis; 2005; 2(5):261-6. PubMed ID: 16909007
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward.
Panza F; Solfrizzi V; Imbimbo BP; Tortelli R; Santamato A; Logroscino G
Expert Rev Clin Immunol; 2014 Mar; 10(3):405-19. PubMed ID: 24490853
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for Alzheimer's disease: rational basis in ongoing clinical trials.
Menéndez-González M; Pérez-Piñera P; Martínez-Rivera M; Muñiz AL; Vega JA
Curr Pharm Des; 2011; 17(5):508-20. PubMed ID: 21375481
[TBL] [Abstract][Full Text] [Related]
17. Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis.
Boche D; Denham N; Holmes C; Nicoll JA
Acta Neuropathol; 2010 Sep; 120(3):369-84. PubMed ID: 20632020
[TBL] [Abstract][Full Text] [Related]
18. Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.
Cribbs DH
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):207-16. PubMed ID: 20205639
[TBL] [Abstract][Full Text] [Related]
19. [Current trend of immunotherapy for Alzheimer's disease].
Matsumoto SE; Tabira T
Nihon Rinsho; 2011 Sep; 69(9):1628-32. PubMed ID: 21922765
[TBL] [Abstract][Full Text] [Related]
20. [Amyloid-beta protein vaccine therapy for alzheimer's disease].
Hara H
Nihon Naika Gakkai Zasshi; 2006 Jun; 95(6):1122-8. PubMed ID: 16846064
[No Abstract] [Full Text] [Related]
[Next] [New Search]